Full-Time

Medical Assistant Lead

Posted on 5/9/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$19.37 - $27.71/hr

Boston, MA, USA

In Person

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • High School Diploma or Equivalent is required.
  • The role does not accept experience in lieu of a degree.
  • Certified Medical Assistant - Data Conversion - Various Issuers is required.
  • Experience as a medical assistant with demonstrated proficiency in clinical and administrative tasks is required (3-5 years).
  • Strong leadership and team management skills.
  • Comprehensive knowledge of medical terminology, procedures, and protocols.
  • Proficiency in electronic health record systems and medical office software.
  • Ability to take vital signs, manual blood pressure, and collect blood samples and other specimens.
  • Excellent interpersonal and communication skills, both written and verbal.
  • Attention to detail and strong organizational abilities.
  • Ability to multitask, prioritize, and adapt in a fast-paced healthcare environment.
  • Knowledge of HIPAA and other privacy and security regulations.
Responsibilities
  • Assists in complex office-based procedures and provides clinical oversight for quality control programs.
  • Provide leadership to the medical assisting team, including training, mentoring, and performance guidance.
  • Assign tasks and responsibilities to team members, ensuring proper workload distribution and effective utilization of resources.
  • Foster a positive and collaborative team environment, promoting teamwork and professional growth.
  • Coordinate patient flow, ensuring timely and efficient delivery of care.
  • Assist with patient intake, including obtaining medical history, vital signs, and preparing patients for examination.
  • Participates in the interview process for new MAs and serves as a preceptor for new hires or students, supervising clinic support staff and creating coverage schedules for the MA team.
  • Assists with competency assessment for other MAs and provides input on performance evaluations.
Desired Qualifications
  • Basic Life Support [BLS Certification] - Data Conversion - Various Issuers preferred

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.7B

Headquarters

Cambridge, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mass General Brigham who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.

Fierce Biotech
Feb 12th, 2025
Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody

Sanofi-backed Abcuro has secured